Published On : February 2024 Email: help@24marketreports.com Global Meningococcal Vaccine Market Research Report 2024(Status and Outlook)
Report Studies
• Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years.
• They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
• Meningococcal Vaccine Market provides a deep insight into the global Meningococcal Vaccine market covering all its essential aspects.
Email: help@24marketreports.com Call:
+1(646)-781-7170 (Int'l)
Email: help@24marketreports.com Call: +1(646)-781-7170 (Int'l) By Types Meningtits A Polysaccharide Meningtitis AC Meningitis ACYW
Email: help@24marketreports.com Call: +1(646)-781-7170 (Int'l) By Applications • 6 Months-15Year • over 3 Year • over 2 Year • over 3 Months $0 $10,000 $20,000 $30,000 $40,000 $50,000 $0 $5,000 $10,000 $15,000 $20,000 $25,000 $30,000 $35,000
©All Rights Reserved, 24 Market Reports +1(646)-781-7170 (Int'l) Get in touch E-mail: help@24marketreports.com Call : +91 8087042414 (Asia) Call : www.24marketreports.com URL: Full Report URL: https://www.24marketreports.com/life-sciences/global-meningococcal-vaccine2024-935